Developing a new imaging technique to detect prostate cancer in African American men
Official title: Pilot Project 1
Funded at Johns Hopkins University · NIH-11012040 · Data updated 2026-11-12
This study is testing a new, gentle imaging technique to help find and understand prostate cancer better, especially for African American men who are at greater risk, with the hope of catching the disease earlier and improving treatment options.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | September 20, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $23,259 |
| NIH project number | 1U54CA295336-01 |
| Project ID | NIH-11012040 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are African American men who are at risk for or diagnosed with prostate cancer.
✕Less likely to help
Patients who do not identify as African American or those without prostate cancer may not benefit from this research.
What this research studies
This research focuses on creating a non-invasive imaging method using molecular CEST MRI technology to improve the detection and prognosis of prostate cancer, particularly in African American men who are at higher risk. The approach combines advanced MRI techniques with machine learning to enhance image resolution and metabolic analysis of tumors. By simulating metabolic activity in vascular networks, the study aims to provide more accurate assessments of cancer aggressiveness, which could lead to earlier detection and better treatment outcomes. The research is designed to address the significant health disparities faced by underserved communities.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate detection of prostate cancer, potentially reducing mortality rates in African American men.
How similar studies have gone: Previous research has shown promise in using advanced imaging techniques and machine learning for cancer detection, suggesting that this approach could be effective.
Where this research is happening
-
Johns Hopkins University
Baltimore, United States Active
Researchers
- Principal investigator: Deville, Curtiland — Johns Hopkins University
- Study coordinator: Deville, Curtiland
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.